Table of Content

Table of Contents
Table of Contents
1 Industry Overview
1.1 Nano-drug Industry
Figure Nano-drug Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Nano-drug
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Nano-drug
1.2.2 Downstream
Table Application Segment of Nano-drug
Table Global Nano-drug Market 2016-2026, by Application, in USD Million
1.2.3 COVID-19 Impact
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Nano-drug Market by Type
3.1 By Type
3.1.1 Liposomes 
Table Major Company List of Liposomes 
3.1.2 Polymeric Micelles 
Table Major Company List of Polymeric Micelles 
3.1.3 Solid lipid Nanoparticles 
Table Major Company List of Solid lipid Nanoparticles 
3.1.4 Microemulsion and Nanoemulsion 
Table Major Company List of Microemulsion and Nanoemulsion 
3.1.5 Nanosuspension
Table Major Company List of Nanosuspension
3.2 Market Size
Table Global Nano-drug Market 2016-2020, by Type, in USD Million
Figure Global Nano-drug Market Growth 2016-2020, by Type, in USD Million
Table Global Nano-drug Market 2016-2020, by Type, in Volume
Figure Global Nano-drug Market Growth 2016-2020, by Type, in Volume
3.3 Market Forecast
Table Global Nano-drug Market Forecast 2021-2026, by Type, in USD Million
Table Global Nano-drug Market Forecast 2021-2026, by Type, in Volume
4 Major Companies List
4.1 Merck  (Company Profile, Sales Data etc.)
4.1.1 Merck  Profile
Table Merck  Overview List
4.1.2 Merck  Products & Services
4.1.3 Merck  Business Operation Conditions
Table Business Operation of Merck  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 Pfizer  (Company Profile, Sales Data etc.)
4.2.1 Pfizer  Profile
Table Pfizer  Overview List
4.2.2 Pfizer  Products & Services
4.2.3 Pfizer  Business Operation Conditions
Table Business Operation of Pfizer  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 Novartis  (Company Profile, Sales Data etc.)
4.3.1 Novartis  Profile
Table Novartis  Overview List
4.3.2 Novartis  Products & Services
4.3.3 Novartis  Business Operation Conditions
Table Business Operation of Novartis  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 Abbott  (Company Profile, Sales Data etc.)
4.4.1 Abbott  Profile
Table Abbott  Overview List
4.4.2 Abbott  Products & Services
4.4.3 Abbott  Business Operation Conditions
Table Business Operation of Abbott  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 GlaxoSmithKline  (Company Profile, Sales Data etc.)
4.5.1 GlaxoSmithKline  Profile
Table GlaxoSmithKline  Overview List
4.5.2 GlaxoSmithKline  Products & Services
4.5.3 GlaxoSmithKline  Business Operation Conditions
Table Business Operation of GlaxoSmithKline  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 Roche  (Company Profile, Sales Data etc.)
4.6.1 Roche  Profile
Table Roche  Overview List
4.6.2 Roche  Products & Services
4.6.3 Roche  Business Operation Conditions
Table Business Operation of Roche  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 Sanofi  (Company Profile, Sales Data etc.)
4.7.1 Sanofi  Profile
Table Sanofi  Overview List
4.7.2 Sanofi  Products & Services
4.7.3 Sanofi  Business Operation Conditions
Table Business Operation of Sanofi  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.8 Eli Lilly  (Company Profile, Sales Data etc.)
4.8.1 Eli Lilly  Profile
Table Eli Lilly  Overview List
4.8.2 Eli Lilly  Products & Services
4.8.3 Eli Lilly  Business Operation Conditions
Table Business Operation of Eli Lilly  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.9 Astrazeneca  (Company Profile, Sales Data etc.)
4.9.1 Astrazeneca  Profile
Table Astrazeneca  Overview List
4.9.2 Astrazeneca  Products & Services
4.9.3 Astrazeneca  Business Operation Conditions
Table Business Operation of Astrazeneca  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.10 Johnson & Johnson  (Company Profile, Sales Data etc.)
4.10.1 Johnson & Johnson  Profile
Table Johnson & Johnson  Overview List
4.10.2 Johnson & Johnson  Products & Services
4.10.3 Johnson & Johnson  Business Operation Conditions
Table Business Operation of Johnson & Johnson  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.11 Celgene  (Company Profile, Sales Data etc.)
4.11.1 Celgene  Profile
Table Celgene  Overview List
4.11.2 Celgene  Products & Services
4.11.3 Celgene  Business Operation Conditions
Table Business Operation of Celgene  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.12 Novavax  (Company Profile, Sales Data etc.)
4.12.1 Novavax  Profile
Table Novavax  Overview List
4.12.2 Novavax  Products & Services
4.12.3 Novavax  Business Operation Conditions
Table Business Operation of Novavax  (Sales Revenue, Cost, Gross Margin)
4.13 Stryker  (Company Profile, Sales Data etc.)
4.13.1 Stryker  Profile
Table Stryker  Overview List
4.13.2 Stryker  Products & Services
4.13.3 Stryker  Business Operation Conditions
Table Business Operation of Stryker  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.14 Gilead Sciences  (Company Profile, Sales Data etc.)
4.14.1 Gilead Sciences  Profile
Table Gilead Sciences  Overview List
4.14.2 Gilead Sciences  Products & Services
4.14.3 Gilead Sciences  Business Operation Conditions
Table Business Operation of Gilead Sciences  (Sales Revenue, Cost, Gross Margin)
4.15 OSI Pharmaceuticals  (Company Profile, Sales Data etc.)
4.15.1 OSI Pharmaceuticals  Profile
Table OSI Pharmaceuticals  Overview List
4.15.2 OSI Pharmaceuticals  Products & Services
4.15.3 OSI Pharmaceuticals  Business Operation Conditions
Table Business Operation of OSI Pharmaceuticals  (Sales Revenue, Cost, Gross Margin)
4.16 Kadmon Pharmaceuticals  (Company Profile, Sales Data etc.)
4.16.1 Kadmon Pharmaceuticals  Profile
Table Kadmon Pharmaceuticals  Overview List
4.16.2 Kadmon Pharmaceuticals  Products & Services
4.16.3 Kadmon Pharmaceuticals  Business Operation Conditions
Table Business Operation of Kadmon Pharmaceuticals  (Sales Revenue, Cost, Gross Margin)
4.17 Samyang Biopharm  (Company Profile, Sales Data etc.)
4.17.1 Samyang Biopharm  Profile
Table Samyang Biopharm  Overview List
4.17.2 Samyang Biopharm  Products & Services
4.17.3 Samyang Biopharm  Business Operation Conditions
Table Business Operation of Samyang Biopharm  (Sales Revenue, Cost, Gross Margin)
4.18 Mitsubishi Pharma  (Company Profile, Sales Data etc.)
4.18.1 Mitsubishi Pharma  Profile
Table Mitsubishi Pharma  Overview List
4.18.2 Mitsubishi Pharma  Products & Services
4.18.3 Mitsubishi Pharma  Business Operation Conditions
Table Business Operation of Mitsubishi Pharma  (Sales Revenue, Cost, Gross Margin)
4.19 Kaken Pharmaceutical  (Company Profile, Sales Data etc.)
4.19.1 Kaken Pharmaceutical  Profile
Table Kaken Pharmaceutical  Overview List
4.19.2 Kaken Pharmaceutical  Products & Services
4.19.3 Kaken Pharmaceutical  Business Operation Conditions
Table Business Operation of Kaken Pharmaceutical  (Sales Revenue, Cost, Gross Margin)
4.20 Selecta Biosciences  (Company Profile, Sales Data etc.)
4.20.1 Selecta Biosciences  Profile
Table Selecta Biosciences  Overview List
4.20.2 Selecta Biosciences  Products & Services
4.20.3 Selecta Biosciences  Business Operation Conditions
Table Business Operation of Selecta Biosciences  (Sales Revenue, Cost, Gross Margin)
4.21 Par Pharmaceutical  (Company Profile, Sales Data etc.)
4.21.1 Par Pharmaceutical  Profile
Table Par Pharmaceutical  Overview List
4.21.2 Par Pharmaceutical  Products & Services
4.21.3 Par Pharmaceutical  Business Operation Conditions
Table Business Operation of Par Pharmaceutical  (Sales Revenue, Cost, Gross Margin)
4.22 Cerulean Pharma  (Company Profile, Sales Data etc.)
4.22.1 Cerulean Pharma  Profile
Table Cerulean Pharma  Overview List
4.22.2 Cerulean Pharma  Products & Services
4.22.3 Cerulean Pharma  Business Operation Conditions
Table Business Operation of Cerulean Pharma  (Sales Revenue, Cost, Gross Margin)
4.23 Navidea Biopharmaceuticals  (Company Profile, Sales Data etc.)
4.23.1 Navidea Biopharmaceuticals  Profile
Table Navidea Biopharmaceuticals  Overview List
4.23.2 Navidea Biopharmaceuticals  Products & Services
4.23.3 Navidea Biopharmaceuticals  Business Operation Conditions
Table Business Operation of Navidea Biopharmaceuticals  (Sales Revenue, Cost, Gross Margin)
4.24 Lummy (Company Profile, Sales Data etc.)
4.24.1 Lummy Profile
Table Lummy Overview List
4.24.2 Lummy Products & Services
4.24.3 Lummy Business Operation Conditions
Table Business Operation of Lummy (Sales Revenue, Cost, Gross Margin)
5 Market Competition
5.1 Company Competition
Table Global Nano-drug Sales Revenue 2016-2020, by Company, in USD Million
Table Global Nano-drug Sales Revenue Share 2016-2020, by Company, in USD Million
Figure Global Nano-drug Sales Revenue Share in 2020, by Company, in USD Million
Table Global Nano-drug Sales Volume 2016-2020, by Company, in Volume
Table Global Nano-drug Sales Volume Share 2016-2020, by Company, in Volume
Figure Global Nano-drug Sales Volume Share in 2020, by Company, in Volume
5.2 Regional Market by Company
Figure North America Nano-drug Market Concentration, in 2020
Figure Europe Nano-drug Market Market Concentration, in 2020
Figure Asia-Pacific Nano-drug MMarket Concentration, in 2020
Figure South America Nano-drug Market Concentration, in 2020
Figure Middle East & Africa Nano-drug Market Concentration, in 2020
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Cancer and Tumors 
Figure Nano-drug Demand in Cancer and Tumors , 2016-2020, in USD Million
Figure Nano-drug Demand in Cancer and Tumors , 2016-2020, in Volume
6.1.2 Demand in Autoimmune Disorders
Figure Nano-drug Demand in Autoimmune Disorders, 2016-2020, in USD Million
Figure Nano-drug Demand in Autoimmune Disorders, 2016-2020, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Nano-drug Demand Forecast 2021-2026, by Application, in USD Million
Figure Nano-drug Market Growth 2021-2026, by Application, in USD Million
Figure Nano-drug Market Share in 2026, by Application, in USD Million
Table Nano-drug Demand Forecast 2021-2026, by Application, in Volume
Table Nano-drug Market Growth 2021-2026, by Application, in Volume
Table Nano-drug Market Share in 2026, by Application, in Volume
6.4 Impact of the COVID-19 on the Demand
7 Region Operation
7.1 Regional Production
Table Nano-drug Production 2016-2020, by Region, in USD Million
Table Nano-drug Production 2016-2020, by Region, in Volume
7.2 Regional Market
Table Global Nano-drug Market 2016-2020, by Region, in USD Million
Table Global Nano-drug Market Share 2016-2020, by Region, in USD Million
Table Global Nano-drug Market 2016-2020, by Region, in Volume
Table Global Nano-drug Market Share 2016-2020, by Region, in Volume
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America Nano-drug Market Size and Growth 2016-2020, in USD Million
Figure North America Nano-drug Market Size and Growth 2016-2020, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Nano-drug Market Size 2016-2020, by Country, in USD Million
Table North America Nano-drug Market Size 2016-2020, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe Nano-drug Market Size and Growth 2016-2020, in USD Million
Figure Europe Nano-drug Market Size and Growth 2016-2020, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Nano-drug Market Size 2016-2020, by Country, in USD Million
Table Europe Nano-drug Market Size 2016-2020, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific Nano-drug Market Size and Growth 2016-2020, in USD Million
Figure Asia-Pacific Nano-drug Market Size and Growth 2016-2020, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Nano-drug Market Size 2016-2020, by Country, in USD Million
Table Asia-Pacific Nano-drug Market Size 2016-2020, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America Nano-drug Market Size and Growth 2016-2020, in USD Million
Figure South America Nano-drug Market Size and Growth 2016-2020, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Nano-drug Market Size 2016-2020, by Country, in USD Million
Table South America Nano-drug Market Size 2016-2020, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa Nano-drug Market Size and Growth 2016-2020, in USD Million
Figure Middle East & Africa Nano-drug Market Size and Growth 2016-2020, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Nano-drug Market Size 2016-2020, by Country, in USD Million
Table Middle East & Africa Nano-drug Market Size 2016-2020, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table Nano-drug Market Forecast 2021-2026, by Region, in USD Million
Table Nano-drug Market Forecast 2021-2026, by Region, in Volume
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion

List of Figure

List of Table
List of Table
1. Table Upstream Segment of Nano-drug
2. Table Application Segment of Nano-drug
3. Table Global Nano-drug Market 2016-2026, by Application, in USD Million
4. Table Major Company List of Polymeric Micelles 
5. Table Major Company List of Solid lipid Nanoparticles 
6. Table Major Company List of Microemulsion and Nanoemulsion 
7. Table Major Company List of Nanosuspension
8. Table Global Nano-drug Market 2016-2020, by Type, in USD Million
9. Table Global Nano-drug Market 2016-2020, by Type, in Volume
10. Table Global Nano-drug Market Forecast 2021-2026, by Type, in USD Million
11. Table Global Nano-drug Market Forecast 2021-2026, by Type, in Volume
12. Table Merck  Overview List
13. Table Business Operation of Merck  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
14. Table Pfizer  Overview List
15. Table Business Operation of Pfizer  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
16. Table Novartis  Overview List
17. Table Business Operation of Novartis  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
18. Table Abbott  Overview List
19. Table Business Operation of Abbott  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
20. Table GlaxoSmithKline  Overview List
21. Table Business Operation of GlaxoSmithKline  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
22. Table Roche  Overview List
23. Table Business Operation of Roche  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
24. Table Sanofi  Overview List
25. Table Business Operation of Sanofi  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
26. Table Eli Lilly  Overview List
27. Table Business Operation of Eli Lilly  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
28. Table Astrazeneca  Overview List
29. Table Business Operation of Astrazeneca  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
30. Table Johnson & Johnson  Overview List
31. Table Business Operation of Johnson & Johnson  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
32. Table Celgene  Overview List
33. Table Business Operation of Celgene  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
34. Table Novavax  Overview List
35. Table Business Operation of Novavax  (Sales Revenue, Cost, Gross Margin)
36. Table Stryker  Overview List
37. Table Business Operation of Stryker  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
38. Table Gilead Sciences  Overview List
39. Table Business Operation of Gilead Sciences  (Sales Revenue, Cost, Gross Margin)
40. Table OSI Pharmaceuticals  Overview List
41. Table Business Operation of OSI Pharmaceuticals  (Sales Revenue, Cost, Gross Margin)
42. Table Kadmon Pharmaceuticals  Overview List
43. Table Business Operation of Kadmon Pharmaceuticals  (Sales Revenue, Cost, Gross Margin)
44. Table Samyang Biopharm  Overview List
45. Table Business Operation of Samyang Biopharm  (Sales Revenue, Cost, Gross Margin)
46. Table Mitsubishi Pharma  Overview List
47. Table Business Operation of Mitsubishi Pharma  (Sales Revenue, Cost, Gross Margin)
48. Table Kaken Pharmaceutical  Overview List
49. Table Business Operation of Kaken Pharmaceutical  (Sales Revenue, Cost, Gross Margin)
50. Table Selecta Biosciences  Overview List
51. Table Business Operation of Selecta Biosciences  (Sales Revenue, Cost, Gross Margin)
52. Table Par Pharmaceutical  Overview List
53. Table Business Operation of Par Pharmaceutical  (Sales Revenue, Cost, Gross Margin)
54. Table Cerulean Pharma  Overview List
55. Table Business Operation of Cerulean Pharma  (Sales Revenue, Cost, Gross Margin)
56. Table Navidea Biopharmaceuticals  Overview List
57. Table Business Operation of Navidea Biopharmaceuticals  (Sales Revenue, Cost, Gross Margin)
58. Table Lummy Overview List
59. Table Business Operation of Lummy (Sales Revenue, Cost, Gross Margin)
60. Table Global Nano-drug Sales Revenue 2016-2020, by Company, in USD Million
61. Table Global Nano-drug Sales Revenue Share 2016-2020, by Company, in USD Million
62. Table Global Nano-drug Sales Volume 2016-2020, by Company, in Volume
63. Table Global Nano-drug Sales Volume Share 2016-2020, by Company, in Volume
64. Table Regional Demand Comparison List
65. Table Major Application in Different Regions
66. Table Nano-drug Demand Forecast 2021-2026, by Application, in USD Million
67. Table Nano-drug Demand Forecast 2021-2026, by Application, in Volume
68. Table Nano-drug Market Growth 2021-2026, by Application, in Volume
69. Table Nano-drug Market Share in 2026, by Application, in Volume
70. Table Nano-drug Production 2016-2020, by Region, in USD Million
71. Table Nano-drug Production 2016-2020, by Region, in Volume
72. Table Global Nano-drug Market 2016-2020, by Region, in USD Million
73. Table Global Nano-drug Market Share 2016-2020, by Region, in USD Million
74. Table Global Nano-drug Market 2016-2020, by Region, in Volume
75. Table Global Nano-drug Market Share 2016-2020, by Region, in Volume
76. Table North America Nano-drug Market Size 2016-2020, by Country, in USD Million
77. Table North America Nano-drug Market Size 2016-2020, by Country, in Volume
78. Table Europe Nano-drug Market Size 2016-2020, by Country, in USD Million
79. Table Europe Nano-drug Market Size 2016-2020, by Country, in Volume
80. Table Asia-Pacific Nano-drug Market Size 2016-2020, by Country, in USD Million
81. Table Asia-Pacific Nano-drug Market Size 2016-2020, by Country, in Volume
82. Table South America Nano-drug Market Size 2016-2020, by Country, in USD Million
83. Table South America Nano-drug Market Size 2016-2020, by Country, in Volume
84. Table Middle East & Africa Nano-drug Market Size 2016-2020, by Country, in USD Million
85. Table Middle East & Africa Nano-drug Market Size 2016-2020, by Country, in Volume
86. Table Nano-drug Market Forecast 2021-2026, by Region, in USD Million
87. Table Nano-drug Market Forecast 2021-2026, by Region, in Volume
88. Table Price Factors List